Survival Rates for Liver Cancer

The survival time for liver cancer largely depends on how early the disease is detected and the effectiveness of treatment. In cases where liver cancer is diagnosed at an early stage, the five-year survival rate can be relatively high, exceeding 50%. For very early-stage small liver tumors, patients may even live for 20 years or more following treatments such as surgical resection or interventional therapy.

Unfortunately, most liver cancer cases are diagnosed at an intermediate or advanced stage, where multiple lesions may be present in the liver, often accompanied by vascular invasion, lymph node involvement, or even bone metastasis. At this point, the effectiveness of interventional treatments alone becomes limited.

For patients with intermediate-stage liver cancer undergoing interventional therapy, the average survival time is approximately 20 months. In advanced cases, interventional procedures must often be combined with targeted therapy or immunotherapy to extend survival. With this combined approach, the average survival time typically ranges between 12 to 15 months.

Early detection and a personalized treatment plan are crucial for improving outcomes in liver cancer patients. Regular screenings and prompt medical consultation can significantly impact prognosis, especially for individuals at higher risk due to conditions like cirrhosis or chronic hepatitis.